PubHawk
March 2022 PMID 34747186

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.

Roberto Galea, Federico De Marco, Nicolas Meneveau, Adel Aminian, Frédéric Anselme, Christoph Gräni, Adrian T Huber, Emmanuel Teiger, Xavier Iriart, Flora Babongo Bosombo, Dik Heg, Anna Franzone, Pascal Vranckx, Urs Fischer, Giovanni Pedrazzini

Full text PDF Download social card

Mentions

52
Peak: 15 in Mar 2022
across 4 sources since Nov 2021

Extended reach

214,965
potential audience

Total likes

159

Video views

1,818

Mentions per month

Nov 2021 – Oct 2025

Where it's discussed

  • X / Twitter46 posts
  • News3 articles
  • YouTube2 videos
  • Blogs1 articles

AI synopsis

What people are saying

The discussions reflect an overall positive reception, emphasizing the comparative effectiveness and safety profiles of the Amulet and Watchman devices, with participants using technical language like 'residual LAA patency' and 'procedural complications' to underline the study's clinical relevance, thus highlighting a meaningful impact on practice.

AgreementModerate agreement

Most discussions acknowledge the study's findings, with many highlighting its significance and congratulating the authors, indicating general consensus and support.

InterestHigh interest

The discussions demonstrate high engagement with the topic, referencing specific details like procedural complications and device comparisons, showing a strong interest in the research and its clinical implications.

EngagementModerate engagement

Posts delve into methodological details such as residual LAA patency and PDL rates, suggesting moderate to deep engagement that goes beyond surface-level reactions.

ImpactModerate impact

The prominent mentions of presenting at major conferences and the detailed analysis suggest the study could influence clinical practices regarding device choice and safety profiles.

Abstract in brief

  • The SWISSAPERO trial compared Amulet and Watchman FLX devices for left atrial appendage (LAA) closure, focusing on residual LAA patency and clinical outcomes, and found similar effectiveness between the two devices.
  • Major procedural complications were more common with the Amulet device, mainly due to increased bleeding, while the Watchman had a higher rate of peridevice leaks, though none were clinically significant.
  • Overall, the study suggests both devices are effective for LAA closure, but they have different safety profiles and complication risks that clinicians should consider.]
Read the full abstract

Top posts

Most liked on X and Bluesky
RTHahnMD
@hahn_rt · X

Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adnanalkhouli @docsaw @escardio @ESC_Journals @ASE360 See also: https://t.co/sexLH8z10n, https://t.co/22t83imeja  https://t.co/6re6VymlFM https://t.co/mVaB72vA97

Jan 14, 2024 · 95 likes · 34 shares · 15,462 followers View post →
Circulation
@CircAHA · X

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial #AHAJournals https://t.co/QVIKtgkOJO https://t.co/rYX9dVM5e5

Mar 10, 2022 · 16 likes · 12 shares · 77,716 followers View post →
Lorenz Räber, MD PhD
@RaberLorenz · X

Congratulations to @RobertoGalea7 @vlgmrc for conducting the Swiss Apero currently presented at Orlando & simultaneously published in Circulation ⬇️https://t.co/CTyi8kbB9k

Nov 6, 2021 · 13 likes · 3 shares · 1,411 followers View post →
Hetal H. Mehta, MD, FACC, FSCAI
@DocMehta407 · X

In SWISS-APERO RCT, Amulet device compared to Watchman FLX was a/w similar residual LAA patency at 45d CCTA, lower PDL rates at 45d TEE, similar 45d clinical outcomes but higher procedural complications @vlgmrc @TCTMD @crfheart @TCTConference @CircAHA https://t.co/ik3EgSaR8e https://t.co/Hrmy0deZfF

Nov 6, 2021 · 4 likes · 1 share · 413 followers View post →
Lorenz Räber, MD PhD
@RaberLorenz · X

@thiele_holger @AGIKinterv @vlgmrc @PhilippLurz @TobiasKister @Mo_A_W https://t.co/CTyi8kbB9k

Nov 6, 2021 · 3 likes · 1 share · 1,411 followers View post →
Takeki Suzuki
@takekisuzuki · X

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial https://t.co/7CsV1MEPNc

Mar 8, 2022 · 3 likes · 921 followers View post →

All mentions

Abbas (Reza) Emaminia
@RezaEmaminia · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 5,083 followers View post →
David R. Axline, MD, FACC
@PU84 · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 544 followers View post →
Ricardo Román Carpio
@RicardoRoman_ · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 32 followers View post →
Mehnaz Rahman, M.D.
@MehnazRahmanMD · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 962 followers View post →
Murad Alsumat
@MuradAlsumat · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 657 followers View post →
Antonio Carlos Leite de Barros Filho
@AntonioBarros_ · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 2,542 followers View post →
Obayda Azizy
@O_Azizy_MD · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 4,788 followers View post →
duyguinanMD
@MDuyguinan · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 298 followers View post →
David de las Cuevas
@DaviddlCuevas · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 1,393 followers View post →
Nadeen N. Faza, M.D.
@NadeenFaza · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 8,294 followers View post →
Mohamad Alkhouli
@adnanalkhouli · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 16,543 followers View post →
Moaaz Elsharabassy
@melsharabasssy · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 760 followers View post →
Sergio R. de Leiras
@srdeleiras · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 2,433 followers View post →
Sarah Moharem Elgamal, MBBCh, MSc, PhD
@Sarah_Moharem · X

RT @hahn_rt: Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adna…

Jan 14, 2024 · 34 shares · 5,331 followers View post →
RTHahnMD
@hahn_rt · X

Meta-analysis: PDL post-LAAO by TEE a/w adverse events. PDL by CT lacks prognostic significance. https://t.co/jOGI3cgcOw @adnanalkhouli @docsaw @escardio @ESC_Journals @ASE360 See also: https://t.co/sexLH8z10n, https://t.co/22t83imeja  https://t.co/6re6VymlFM https://t.co/mVaB72vA97

Jan 14, 2024 · 95 likes · 34 shares · 15,462 followers View post →
Cardiovascular Research Cluster (CVRC)
@BernCVRC · X

New publication: “One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial”. Congratulations to the authors! https://t.co/CIoXStoc1y @RobertoGalea7 @vlgmrc #BernCVRC

Nov 22, 2023 · 2 likes · 385 followers View post →
Trip Database
@tripdatabase · X

New2Trip: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of SWISS-APERO Randomized Clinical Trial https://t.co/5Y77zB0xbd

May 9, 2022 · 4,399 followers View post →
Trip Database
@tripdatabase · X

New2Trip: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of SWISS-APERO Randomized Clinical Trial https://t.co/5Y77zB0xbd

May 5, 2022 · 4,399 followers View post →
Trip Database
@tripdatabase · X

New2Trip: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of SWISS-APERO Randomized Clinical Trial https://t.co/5Y77zB0xbd

Apr 28, 2022 · 4,399 followers View post →
Trip Database
@tripdatabase · X

New2Trip: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of SWISS-APERO Randomized Clinical Trial https://t.co/5Y77zB0xbd

Apr 21, 2022 · 4,399 followers View post →
UofU Nora Eccles Harrison CVRTI
@NEH_CVRTI · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 17, 2022 · 12 shares · 1,317 followers View post →
Shinya Goto
@sgoto4 · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 15, 2022 · 12 shares · 321 followers View post →
Rodrigo Nunes Cal
@CalZole · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 14, 2022 · 12 shares · 3,383 followers View post →
抗血栓療法
@antithrombosis · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 14, 2022 · 12 shares · 131 followers View post →
CardioAcademic
@CardioAcademic · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 11, 2022 · 12 shares · 3,222 followers View post →
Chris Kowalewski MD
@C_KowalewskiMD · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 11, 2022 · 12 shares · 815 followers View post →
Marcio Montenegro
@MarciMonteg · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 10, 2022 · 12 shares · 2,728 followers View post →
СГАМ
@CGAM2016 · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 10, 2022 · 12 shares · 235 followers View post →
Joseph hill
@josephahill · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 10, 2022 · 12 shares · 2,445 followers View post →
Sankalp Patel
@SankalpPatelDO · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 10, 2022 · 12 shares · 592 followers View post →
Jerrold Levy, MD
@JerroldLevy · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 10, 2022 · 12 shares · 2,482 followers View post →
Xiaoming Jia
@jia_xiaoming · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 10, 2022 · 12 shares · 222 followers View post →
NurseNoodles
@NurseNoodles1 · X

RT @CircAHA: Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinic…

Mar 10, 2022 · 12 shares · 868 followers View post →
Circulation
@CircAHA · X

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial #AHAJournals https://t.co/QVIKtgkOJO https://t.co/rYX9dVM5e5

Mar 10, 2022 · 16 likes · 12 shares · 77,716 followers View post →
Takeki Suzuki
@takekisuzuki · X

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial https://t.co/7CsV1MEPNc

Mar 8, 2022 · 3 likes · 921 followers View post →
Cardiovascular Research Cluster (CVRC)
@BernCVRC · X

RT @RaberLorenz: Congratulations to @RobertoGalea7 @vlgmrc for conducting the Swiss Apero currently presented at Orlando & simultaneously p…

Dec 2, 2021 · 3 shares · 385 followers View post →
ALEXANDRU MISCHIE
@ALEX_MISCHIE · X

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial https://t.co/Ubmq6TkYgs

Nov 8, 2021 · 1 like · 10,258 followers View post →
Marco Valgimigli
@vlgmrc · X

RT @DocMehta407: In SWISS-APERO RCT, Amulet device compared to Watchman FLX was a/w similar residual LAA patency at 45d CCTA, lower PDL rat…

Nov 7, 2021 · 1 share · 2,017 followers View post →
Linda
@wordfinga · X

RT @BryanTanMD: https://t.co/ZZ66Xy75t1 Amulet not noninferior to WATCHMAN for percutaneous LAAC with regards to the primary composite out…

Nov 7, 2021 · 1 share · 4,575 followers View post →
Bryan E. Tan, MD
@BryanTanMD · X

https://t.co/ZZ66Xy75t1 Amulet not noninferior to WATCHMAN for percutaneous LAAC with regards to the primary composite outcome of crossover to nonrandomized device or LAA patency at 45 days on CTA. Similar clinical outcomes at 45 days for both devices. #TCT2021 #cardiotwitter

Nov 6, 2021 · 1 like · 1 share · 1,004 followers View post →
Gianluca Campo
@GianlucaCampo78 · X

RT @RaberLorenz: Congratulations to @RobertoGalea7 @vlgmrc for conducting the Swiss Apero currently presented at Orlando & simultaneously p…

Nov 6, 2021 · 3 shares · 2,406 followers View post →
Hetal H. Mehta, MD, FACC, FSCAI
@DocMehta407 · X

In SWISS-APERO RCT, Amulet device compared to Watchman FLX was a/w similar residual LAA patency at 45d CCTA, lower PDL rates at 45d TEE, similar 45d clinical outcomes but higher procedural complications @vlgmrc @TCTMD @crfheart @TCTConference @CircAHA https://t.co/ik3EgSaR8e https://t.co/Hrmy0deZfF

Nov 6, 2021 · 4 likes · 1 share · 413 followers View post →
Roberto Galea
@RobertoGalea7 · X

RT @RaberLorenz: Congratulations to @RobertoGalea7 @vlgmrc for conducting the Swiss Apero currently presented at Orlando & simultaneously p…

Nov 6, 2021 · 3 shares · 118 followers View post →
Holger Thiele
@thiele_holger · X

RT @RaberLorenz: @thiele_holger @AGIKinterv @vlgmrc @PhilippLurz @TobiasKister @Mo_A_W https://t.co/CTyi8kbB9k

Nov 6, 2021 · 1 share · 7,217 followers View post →
Lorenz Räber, MD PhD
@RaberLorenz · X

@thiele_holger @AGIKinterv @vlgmrc @PhilippLurz @TobiasKister @Mo_A_W https://t.co/CTyi8kbB9k

Nov 6, 2021 · 3 likes · 1 share · 1,411 followers View post →
Lorenz Räber, MD PhD
@RaberLorenz · X

Congratulations to @RobertoGalea7 @vlgmrc for conducting the Swiss Apero currently presented at Orlando & simultaneously published in Circulation ⬇️https://t.co/CTyi8kbB9k

Nov 6, 2021 · 13 likes · 3 shares · 1,411 followers View post →
Amulet Vs Watchman Device for Percutaneous LAA Closure | www ...
Blogs

Reference:www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057859. Related Posts. Large eGFRdiff Signals Much Higher Mortality, CV, & Kidney ...

May 23, 2022 View →
Trial compares two devices used for percutaneous left atrial ...
News

10.1161/CIRCULATIONAHA.121.057859. Keywords. /Health and medicine/Medical specialties/Cardiology. Original Source. https://www.crf.org/crf/news ...

Nov 8, 2021 View →
Is LAA Closure With Amulet Less Leaky? | MedPage Today
News

DOI: 10.1161/CIRCULATIONAHA.121.057859. Secondary Source. Transcatheter Cardiovascular Therapeutics. Source Reference: Lakkireddy D, et al ...

Nov 7, 2021 View →
Head-to-head trial of LAA closure devices yields mixed results ...
News

2021;doi:10.1161/CIRCULATIONAHA.121.057859. Perspective. Back to Top. Dhanunjaya R. Lakkireddy, MD, FACC, FHRS.

Nov 6, 2021 View →